Today's carcinochemotherapy: some of its achievements, failures and prospects.
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000921:Antibody-Producing Cells; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D006131:Growth Inhibitors / Q000627:therapeutic use; D006706:Homeostasis; D006728:Hormones / Q000627:therapeutic use; D007111:Immunity, Cellular; D007519:Isoantigens; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D009536:Niacinamide / Q000627:therapeutic use; D009858:Oncogenic Viruses / Q000276:immunology; D014020:Tissue Extracts / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D006131:Growth Inhibitors; D006728:Hormones; D007519:Isoantigens; D014020:Tissue Extracts; D009536:Niacinamide; D014750:Vincristine; D001215:Asparaginase